(MedPage Today) — MADRID — Two trials looking into the need for 1 year of dual antiplatelet therapy (DAPT) after angioplasty for acute coronary syndrome (ACS) found patients couldn’t do without it entirely.
With early P2Y12 inhibitor monotherapy…
Source link : https://www.medpagetoday.com/meetingcoverage/esc/117283
Author :
Publish date : 2025-09-03 15:36:00
Copyright for syndicated content belongs to the linked Source.
